IBDEI098 ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.4)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.4,686,0)
 ;;=3DNERVOUS SYSTEM^7^82
 ;;^UTILITY(U,$J,358.4,687,0)
 ;;=3DMALIG NEOPLASM (NOT CIS)^4^82
 ;;^UTILITY(U,$J,358.4,688,0)
 ;;=3DBLADDER^1^82
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=3DKIDNEY AND URETER^3^82
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=3DCARCINOMA IN SITU^2^82
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=3DPENIS^5^82
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=3DPROSTATE^6^82
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=3DTESTES AND SCROTUM^8^82
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=3DPOST OP^9^82
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=3DMISCELLANEOUS/SYMPTOMS^10^82
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=3DURETHRA^8.1^82
